Loading...
Disease status, reasons for discontinuation and adverse events in 1038 Italian children with juvenile idiopathic arthritis treated with etanercept
BACKGROUND: Data from routine clinical practice are needed to further define the efficacy and safety of biologic medications in children with juvenile idiopathic arthritis (JIA). The aim of this analysis was to investigate the disease status, reasons for discontinuation and adverse events in Italian...
Saved in:
| Published in: | Pediatr Rheumatol Online J |
|---|---|
| Main Authors: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
| Format: | Artigo |
| Language: | Inglês |
| Published: |
BioMed Central
2016
|
| Subjects: | |
| Online Access: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5170898/ https://ncbi.nlm.nih.gov/pubmed/27993144 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12969-016-0126-0 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|